The NHE inhibitor 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) was used as a control for LASV entry inhibition, and the replication inhibitor Rib was included as an inhibitor of post-entry steps of infection [26,90]. Here, SLC9C1 is linked to infection.